Selected February Publications from BIDMC Faculty

BIDMC Communications mediarelations@bidmc.harvard.edu

MARCH 03, 2022

Building on BIDMC’s culture of collaboration and innovation, our researchers are helping to transform medicine and health care delivery. Below are selected academic publications issued in the month of February.

Machine learning in medical education: a survey of the experiences and opinions of medical students in Ireland
BMJ Health & Care Informatics / Education Report / February 1, 2022
BIDMC Authors: Charlotte Blease, Catherine DesRoches (Department of Medicine)

Cost-effectiveness of antibiotic-eluting envelope for prevention of cardiac implantable electronic device infections in heart failure
Circulation: Cardiovascular Quality and Outcomes / Original Research / February 2, 2022
BIDMC Authors: Ronuk M. Modi, Chia-Liang Liu, Nicolas Isaza, Inbar Raber, Peter Zimetbaum, Daniel B. Kramer, Dhruv S. Kazi (Division of Cardiology, Smith Center for Outcomes Research in Cardiology)

Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder
Expert Review of Anticancer Therapy / Review / February 2, 2022
BIDMC Authors: Michail Alevizakos, Joaquim Bellmunt (Division of Hematology/Oncology)

Perspectives of primary care clinicians in Massachusetts on use of telemedicine with adults aged 65 and older during the COVID-19 pandemic
Preventive Medicine Reports / Original Research / February 8, 2022
BIDMC Authors: Gianna M. Aliberti, Roma Bhatia, Laura B. Desrochers, Elizabeth A. Gilliam, Mara A. Schonberg (Department of Medicine)

Association of pulmonary artery pulsatility index with adverse cardiovascular events across a hospital-based sample
Circulation: Heart Failure / Original Research / February 9, 2022
BIDMC Authors: Dongyu Wang, Elizabeth E. Liu, Jessica K. Wang, Jennifer E. Ho (CardioVascular Institute)

Very early versus early referral for ablation in young patients with newly diagnosed paroxysmal atrial fibrillation
Pace / Original Research / February 12, 2022
BIDMC Authors: Robert N. D'Angelo, Robert W. Yeh, Patricia Tung, Andre D'Avila, Peter J. Zimetbaum (Smith Center for Outcomes Research)

Impact of cirrhosis on outcomes in inflammatory bowel disease hospitalizations
Journal of Clinical Gastroenterology / Original Research / February 14, 2022
BIDMC Authors: Vikas Taneja, Joseph D. Feuerstein (Division of Gastroenterology)

Emerging drug therapies in inflammatory bowel disease
Alimentary Pharmacology & Therapeutics / Review / February 15, 2022
BIDMC Authors: Laurie B. Grossberg, Konstantinos Papamichael, Adam S. Cheifetz (Division of Gastroenterology)

Echocardiographic and other preprocedural predictors of heart failure after TIPS placement in patients with cirrhosis: A single-center 15-year analysis
American Journal of Roentgenology / Original Research / February 16, 2022
BIDMC Authors: Aamir Ali, Ammar Sarwar, Vilas R. Patwardhan, Ariane M. Fraiche, Muhammad M. Tahir, Michael Luo, Jeffrey L. Weinstein, Muhammad Sarib Hussain, Michael P. Curry, Muneeb Ahmed (Department of Radiology, Department of Medicine)

Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human sickle reticulocytes
European Journal of Physiology / Original Research / February 16, 2022
BIDMC Authors: David H. Vandorpe, Alicia Rivera, Seth L. Alper (Division of Nephrology)

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.

Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.